Pat Breen (Clare, Fine Gael)
Link to this: Individually | In context | Oireachtas source

479. To ask the Minister for Health further to Parliamentary Question No. 128 of 5 November 2014, if he will provide an update on the application lodged with the Health Service Executive for the inclusion of the drug, fampyra, for multiple sclerosis in the community drugs scheme; when he expects a decision to issue; and if he will make a statement on the matter. [2829/15]

Kathleen Lynch (Cork North Central, Labour)
Link to this: Individually | In context | Oireachtas source

As was outlined in the reply to your question of the 5th November 2014, a revised application was received by the HSE on the 25th July for the inclusion of Fampridine (Fampyra) on the community drugs schemes. The HSE's Corporate Pharmaceutical Unit has since been engaging with the company seeking improved commercial offering. These engagements have been completed and the HSE is now considering the outcome of those commercial engagements. Fampridine will be assessed along with a range of other applications for reimbursement of medicines for multiple sclerosis and other diseases.